Literature DB >> 15927977

Delayed onset of subendocardial diastolic thinning at rest identifies hypoperfused myocardium.

Jianwen Wang1, Theodore P Abraham, Josef Korinek, Stig Urheim, Eileen M McMahon, Marek Belohlavek.   

Abstract

BACKGROUND: Onset of myocardial relaxation is highly energy dependent. Perfusion and therefore energy substrate delivery are predominantly reduced in the subendocardial myocardium in the early stages of progressive ischemia. We hypothesized that delayed onset of subendocardial diastolic thinning will functionally identify regionally hypoperfused resting myocardium. METHODS AND
RESULTS: Progressive left anterior descending coronary artery stenosis was induced by an ameroid occluder and maintained for 1 or 2 weeks (end point) in 12 dogs. M-mode tissue Doppler images of the anterior apical and middle segments (testing region) and middle inferior segment (control region) were acquired selectively in the subendocardium and subepicardium. The time to the onset of thinning was measured with the use of tissue Doppler velocity (TOTv) and a thickness function (TOTt). At the end point in the testing region, myocardial flow was significantly lower in the subendocardial layer (P<0.05) in all animals, whereas viability staining showed preserved transmural viability in 10 dogs and thin subendocardial necrosis in 2 dogs. Both TOTv and TOTt were significantly (P<0.01) prolonged in the testing region. The mean difference between subendocardial and subepicardial TOTv values versus that in the control region identified the ischemic region, even when only dogs with hypoperfused but transmurally viable myocardium were considered (P<0.05). Systolic and diastolic myocardial velocities did not identify subendocardial hypoperfusion.
CONCLUSIONS: In resting myocardium subtended to progressive coronary stenosis, a delayed onset of subendocardial thinning suggests an early stage of hypoperfusion, before the development of local wall motion abnormalities.

Entities:  

Mesh:

Year:  2005        PMID: 15927977     DOI: 10.1161/CIRCULATIONAHA.104.482984

Source DB:  PubMed          Journal:  Circulation        ISSN: 0009-7322            Impact factor:   29.690


  6 in total

1.  Post-exercise diastolic stunning detected by velocity vector imaging is a useful marker for induced ischemia in ischemic heart disease.

Authors:  Koji Kurosawa; Hiroyuki Watanabe; Masaru Aikawa; Hirotsugu Mihara; Nobuo Iguchi; Ryuta Asano; Jun Umemura; Masahiko Kurabayashi; Tetsuya Sumiyoshi
Journal:  J Echocardiogr       Date:  2013-01-25

2.  The diastolic stress test: a new approach to an old problem.

Authors:  Kamran A Shaikh; Miguel A Quinones
Journal:  Heart Fail Rev       Date:  2011-07       Impact factor: 4.214

3.  Effect of Percutaneous Coronary Intervention on Diastolic Function in Coronary Artery Disease.

Authors:  Puneet Aggarwal; Santosh Kumar Sinha; Rishabh Marwah; Ranjit Kumar Nath; Bhagya Narayan Pandit; Ajay Pratap Singh
Journal:  J Cardiovasc Echogr       Date:  2021-07-28

4.  Metabolomic profiling reveals distinct patterns of tricarboxylic acid disorders in blood stasis syndrome associated with coronary heart disease.

Authors:  Yong Wang; Chun Li; Hong Chang; Ling-Hui Lu; Qi Qiu; Yu-Lin Ouyang; Jun-da Yu; Shu-Zhen Guo; Jing Han; Wei Wang
Journal:  Chin J Integr Med       Date:  2016-05-16       Impact factor: 1.978

5.  Low coronary driving pressure early in the course of myocardial infarction is associated with subendocardial remodelling and left ventricular dysfunction.

Authors:  Marcia Kiyomi Koike; Clovis De Carvalho Frimm; Mariana Cúri
Journal:  Int J Exp Pathol       Date:  2007-08       Impact factor: 1.925

6.  Doppler strain imaging closely reflects myocardial energetic status in acute progressive ischemia and indicates energetic recovery after reperfusion.

Authors:  Josef Korinek; Partho P Sengupta; Jianwen Wang; Abel Romero-Corral; Anna E Boukatina; Jan Vitek; Vijay K Krishnamoorthy; Stephen S Cha; Petras P Dzeja; Andre Terzic; Bijoy K Khandheria; Marek Belohlavek
Journal:  J Am Soc Echocardiogr       Date:  2008-03-06       Impact factor: 5.251

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.